Department of Transplant, Division of Kidney and Pancreas Transplant, Mayo Clinic, Jacksonville, Florida.
Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Jacksonville, Florida.
Transplant Proc. 2023 Apr;55(3):667-671. doi: 10.1016/j.transproceed.2023.02.031. Epub 2023 Mar 21.
Monkeypox is a rapidly spreading infection worldwide and is a public health concern, especially with newly reported fatality cases. The characteristics and disease course of monkeypox infection in transplant recipients remain elusive because no case reports have been published detailing its clinical presentation and outcome in this population. We report a case of a kidney transplant recipient who developed end-stage renal disease secondary to HIV-associated nephropathy and manifested monkeypox infection after kidney transplantation. The patient had severe clinical manifestations, including disseminated vesicular skin rash, diffuse mucosal involvement, urine retention, proctitis, and bowel obstruction. We also highlight several clinical considerations regarding the use of tecovirimat, a novel antiviral therapy with activity against orthopoxviruses that has been used in the United States to treat monkeypox infection.
猴痘是一种在全球范围内迅速传播的感染病,是一个公共卫生关注点,尤其是最近有报告的死亡病例。由于尚未发表详细报告阐明其在该人群中的临床表现和结局,因此,移植受者中猴痘感染的特征和疾病进程仍不清楚。我们报告了 1 例继发于 HIV 相关性肾病的肾移植受者发生终末期肾病,肾移植后出现猴痘感染。该患者临床表现严重,包括播散性水疱性皮疹、弥漫性黏膜受累、尿潴留、直肠炎和肠梗阻。我们还强调了使用特考韦瑞玛(一种新型抗病毒疗法,对正痘病毒具有活性,已在美国用于治疗猴痘感染)时需要考虑的几个临床问题。